CTSO
- Cytosorbents Corporation
()
Overview
Company Summary
Cytosorbents Corporation (CTSO) is a medical device company that specializes in blood purification technology. The company has developed a highly innovative and unique product called CytoSorb, which is intended to be used in a wide range of critical care applications.
The primary function of CytoSorb is to remove harmful substances and toxins from a patient's bloodstream. It works by passing the blood through a highly porous polymer cartridge that acts as a filter. This cartridge is filled with CytoSorbents' proprietary biocompatible adsorbent, which adsorbs, or selectively binds, various toxins and inflammatory mediators present in the blood.
By targeting and removing these harmful substances, CytoSorb aims to address critical conditions associated with high levels of inflammation and organ dysfunction. The technology has shown significant promise in conditions such as sepsis, a septic shock, which are characterized by severe immune response and often lead to multiple organ failure.
Cytosorbents Corporation collaborates with healthcare professionals and hospitals worldwide to integrate CytoSorb into their treatment protocols. The product is used alongside traditional therapies to support patients in critical care settings, including intensive care units (ICUs) and cardiac surgery units.
The company's ultimate goal is to improve patient outcomes and reduce mortality rates in critically ill patients. By removing detrimental substances from the bloodstream, CytoSorb has the potential to enhance the effectiveness of other treatments and therapies, allowing the body to better heal and recover.
Moreover, Cytosorbents Corporation actively engages in research and development to expand the applications of their blood purification technology. They continuously explore new therapeutic areas and work towards obtaining regulatory approvals for additional indications.
In summary, Cytosorbents Corporation is focused on developing and commercializing the CytoSorb blood purification technology, offering a potentially life-saving solution for critically ill patients by removing toxins and inflammatory mediators from the bloodstream.